Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

155

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Major Depressive Disorder

Interventions

DRUG

OPC-14597 (Aripiprazole)

administered orally once daily, 3 to 15 mg daily, 52 weeks

Trial Locations (8)

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region